✦ LIBER ✦

Economic Evaluation of Tegaserod vs. Placebo in the Treatment of Patients with Irritable Bowel Syndrome: An Analysis of the TENOR Study

✍ Scribed by Andrea Bracco; Bengt Jönsson; Jean-Francois Ricci; Michael Drummond; Henry Nyhlin

Book ID: 109078642
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 192 KB
Volume: 10
Category: Article
ISSN: 1098-3015
DOI: 10.1111/j.1524-4733.2007.00179.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Charcoal tablets in the treatment of pat

Charcoal tablets in the treatment of patients with irritable bowel syndrome

✍ Wolf D. Hübner; Ewald H. Moser 📂 Article 📅 2002 🏛 Springer Healthcare Communications 🌐 English ⚖ 100 KB

Clinical trial: asimadoline in the treat

Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome

✍ A. W. MANGEL; J. D. BORNSTEIN; L. R. HAMM; J. BUDA; J. WANG; W. IRISH; D. URSO 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB

The effects of withdrawing tegaserod tre

The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study

✍ K. D. Bardhan; A. Forbes; C. L. Marsden; T. Mason; G. Short 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB

Duloxetine in the treatment of irritable

Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study

✍ Brian P. Brennan; Kate V. Fogarty; Jacqueline L. Roberts; Karina A. Reynolds; Ha 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Abstract ## Objective To assess the efficacy of duloxetine for irritable bowel syndrome (IBS). ## Methods We conducted an open‐label 12‐week trial of duloxetine 60 mg daily in 15 patients with IBS without concurrent major depressive disorder. The primary outcome measure was average abdominal

Double-blind study of an α2 agonist in t

Double-blind study of an α2 agonist in the treatment of irritable bowel syndrome

✍ A. PRIOR; K. M. WILSON; P. J. WHORWELL 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

Clinical trial: dextofisopam in the trea

Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome

✍ S. M. LEVENTER; K. RAUDIBAUGH; C. L. FRISSORA; N. KASSEM; J. C. KEOGH; J. PHILLI 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB